Posted: September 21, 2007
The Food and Drug Administration Revitalization Act (S.1082) has been approved by Congress (see "Congress Expands FDA's Oversight On Drug Safety") and will soon be signed into law (you can read the entire bill here).
Two provisions -- or lack thereof -- of this law stood out to me: (1) a one- or two-year moratorium on direct-to-consumer (DTC) ads for all new drugs did not make it into the bill, and (2) a provision prohibiting the FDA from restricting the sale of turtles less than 10.2 centimeters in diameter as a pet DID make it into the bill (Title VII - Domestic Pet Turtle Market Access; Section 703).
What's the connection between DTC and pet turtles? What new powers over DTC does S.1082 give to the FDA? Did the drug industry get a "Get Out of Jail Free" card on DTC fines?
Read more about this in today's post to Pharma Marketing Blog.
For more posts in related topic areas, see:
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
| Return to Pharma Marketing Blog Topics |